Dave Williamson
XMFGreenwave4
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
Recent Articles by Dave Williamson

Oct 25, 2012
by Dave Williamson
Chelsea: A 25% Pop for Nothing?
Big move for no news.

Oct 25, 2012
by Dave Williamson
Say Goodbye to PSS
A buyout that's a win-win.

Oct 25, 2012
by Dave Williamson
2 Ways Orexigen Is Up
A rare positive dilution.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.